KARIN YOUNG: Open Payments
NPI 1902290323 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$955 in 35 payments from 7 companies in 2025. Trend: 2023 $1,132 · 2024 $987 · 2025 $955
Food & beverage: $910Education: $45
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 23 | $620 |
| Sage Therapeutics, LLC | 5 | $144 |
| Lilly USA, LLC | 2 | $73 |
| Organon LLC | 2 | $53 |
| Astellas Pharma US Inc | 1 | $23 |
| MILLICENT US INC | 1 | $23 |
| PFIZER INC. | 1 | $20 |
Products named: MYFEMBREE, ZURZUVAE, GEMTESA, NEXPLANON, ZEPBOUND, Veozah, FEMLYV, ABRYSVO.
Industry payments across PA — which companies pay providers there.
